Sign in with Google. Opens in new tab
bullish

Alkem Laboratories Ltd (ALKEM IN): Further Upside on Card on US Business and Margin Improvement

466 Views12 Dec 2023 03:30
SUMMARY
  • Alkem Laboratories Ltd (ALKEM IN) is flying high on strong Q2 numbers. The shares rallied 23% since the company announced Q2FY24 result in early November, widely outperforming Nifty Pharma index.
  • In Q2FY24, revenue grew 12% YoY, and gross margin expanded 380bps to 61.4% backed by lower raw material cost and lower intensity of price erosion in US market.
  • For the U.S. business, Alkem is looking at high-single-digit growth in dollar terms for FY24. The company has reiterated FY24 gross margin guidance at 59.0–59.5%.
Discussions
(Paid Plans Only)
chart-bar
x